Previous editions of Flow Matters
Updated Edition - September 2024
Early use of NHF in infants and children
In this update we review the literature with the addition of the PARIS 2 trial and provides an evidence-based approach to implementation of NHF in pediatric patients.
An analysis of published studies reveals the equipment most often used to deliver NHF and most used flow rates.
A review conducted by F&P showed that the flow rates used in the published studies ranged from 10 L/min to 60 L/min, and 84% of the studies required flows ≥ 45 L/min.
ROX Index - a bedside tool for monitoring patients on NHF.
Author: Stanislav Taktov, M.D., Ph.D. The validated ROX index uses just 3 data points to provide an indicator of outcomes in adults with AHRF receiving NHF therapy.
Subscribe to Flow Matters
If you have an enquiry about our products, please provide the following information so a Fisher & Paykel Healthcare representative can contact you. For further details on how this information will be used, see below or go to our privacy statement.PM-622804